Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy

Clinicians should be aware of the potential for the pharmacologic activity of SGLT2 inhibitors to persist long after the standard drug clearance period of five half‐lives, the typical duration used to guide pre‐operative medication recommendations.

Detalles Bibliográficos
Autores principales: Bobrowski, David, Kumar, Reha, Wu, Peter E., Lapointe‐Shaw, Lauren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577244/
https://www.ncbi.nlm.nih.gov/pubmed/34786197
http://dx.doi.org/10.1002/ccr3.5057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577244/
https://www.ncbi.nlm.nih.gov/pubmed/34786197
http://dx.doi.org/10.1002/ccr3.5057

Ejemplares similares